Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnosis and management of secondary causes of steatohepatitis.

Journal of hepatology - 1 Jun 2021

Liebe Roman, Esposito Irene, Bock Hans H, Vom Dahl Stephan, Stindt Jan, Baumann Ulrich, Luedde Tom, Keitel Verena

Abstract excerpt

The term non-alcoholic fatty liver disease (NAFLD) was originally coined to describe hepatic fat deposition as part of the metabolic syndrome. However, a variety of rare hereditary liver and metabolic diseases, intestinal diseases, endocrine disorders and drugs may underlie, mimic, or aggravate NAFLD. In contrast to primary NAFLD, therapeutic interventions are available for many secondary causes of NAFLD....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemical and Drug Induced Liver Injury
Share to Endocrine System Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gastrointestinal Diseases

Share to Genetic Diseases, Inborn

Share to Metabolic Syndrome

Share to Non-alcoholic Fatty Liver Disease

Share to Obesity, Abdominal

Share to Pregnancy Complications

Source

Identifiers

PMID: 33577920
DOI: 10.1016/j.jhep.2021.01.045

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnosis and management of secondary causes of steatohepatitis.PMID 33577920Read ↗

[Secondary causes of fatty liver disease - an update on pathogenesis, diagnosis and treatment strategies].Semantic proximity Read ↗

An overview of the genetics, mechanisms and management of NAFLD and ALDSemantic proximity Read ↗

Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Recent advances in understanding and managing non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies.Semantic proximity Read ↗

Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk FactorsSemantic proximity Read ↗

Non-alcoholic fatty liver disease: what the clinician needs to know.Semantic proximity Read ↗

Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.Semantic proximity Read ↗

Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.Semantic proximity Read ↗

Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease.Semantic proximity Read ↗

NAFLD in 2014: Genetics, diagnostics and therapeutic advances in NAFLD.Semantic proximity Read ↗

Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and TherapeuticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.